de Ledinghen V - Search Results

1

Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.

Boursier J, Canivet CM, Costentin C, Lannes A, Delamarre A, Sturm N, Le Bail B, Michalak S, Oberti F, Hilleret MN, Irles-Depé M, Fouchard I, Hermabessiere P, Barthelon J, Calès P, Cariou B, de Ledinghen V, Roux M. Boursier J, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2023 May;21(5):1243-1251.e12. doi: 10.1016/j.cgh.2022.02.059. Epub 2022 Mar 11. Clin Gastroenterol Hepatol. 2023. PMID: 35288342

2

Case report: secondary biliary cirrhosis possibly related to congenital hepatic fibrosis. Evidence for decreased number of portal branch veins and hypertrophic peribiliary vascular plexus.

de Lédinghen V, Le Bail B, Trillaud H, Bernard PH, Saric J, Balabaud C, Bioulac-Sage P. de Lédinghen V, et al. J Gastroenterol Hepatol. 1998 Jul;13(7):720-4. doi: 10.1111/j.1440-1746.1998.tb00720.x. J Gastroenterol Hepatol. 1998. PMID: 9715424

3

Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation.

Blanc JF, De Ledinghen V, Trimoulet P, Le Bail B, Bernard PH, Saric J, Balabaud C, Bioulac-Sage P. Blanc JF, et al. Among authors: de ledinghen v. J Hepatol. 1999 Feb;30(2):325-9. doi: 10.1016/s0168-8278(99)80080-4. J Hepatol. 1999. PMID: 10068114

4

Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver.

Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, Carles J, Saric J, Balabaud C, Bioulac-Sage P. Blanc JF, et al. Among authors: de verneuil h, de ledinghen v. J Hepatol. 2000 May;32(5):805-11. doi: 10.1016/s0168-8278(00)80250-0. J Hepatol. 2000. PMID: 10845668

5

Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients.

de Lédinghen V, Laharie D, Lecesne R, Le Bail B, Winnock M, Bernard PH, Saric J, Couzigou P, Balabaud C, Bioulac-Sage P, Drouillard J. de Lédinghen V, et al. Eur J Gastroenterol Hepatol. 2002 Feb;14(2):159-65. doi: 10.1097/00042737-200202000-00010. Eur J Gastroenterol Hepatol. 2002. PMID: 11981340

6

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V. Castéra L, et al. Among authors: de ledinghen v. Gastroenterology. 2005 Feb;128(2):343-50. doi: 10.1053/j.gastro.2004.11.018. Gastroenterology. 2005. PMID: 15685546

7

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V, Poynard T; LIDO Study Group; CYTOL study group. Ratziu V, et al. Among authors: de ledinghen v. BMC Gastroenterol. 2006 Feb 14;6:6. doi: 10.1186/1471-230X-6-6. BMC Gastroenterol. 2006. PMID: 16503961 Free PMC article.

8

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Française pour l'Etude du Foie Groupe Epidémiologie et Evaluation; Association Nationale des Gastroentérologues des Hôpitaux généraux de France. de Lédinghen V, et al. J Hepatol. 2006 Oct;45(4):592-9. doi: 10.1016/j.jhep.2006.05.008. Epub 2006 Jun 16. J Hepatol. 2006. PMID: 16837098 Clinical Trial.

9

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.

Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V; LIDO Study Group; CYTOL study group. Poynard T, et al. Among authors: de ledinghen v. BMC Gastroenterol. 2006 Nov 10;6:34. doi: 10.1186/1471-230X-6-34. BMC Gastroenterol. 2006. PMID: 17096854 Free PMC article.

10

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

Castéra L, Loko MA, Le Bail B, Coffie P, De Ledinghen V, Trimoulet P, Winnock M, Dabis F, Neau D; Groupe D'epidémiologie Clinique du Sida en Aquitaine (GECSA). Castéra L, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2007 Dec;26(11-12):1489-98. doi: 10.1111/j.1365-2036.2007.03533.x. Epub 2007 Sep 28. Aliment Pharmacol Ther. 2007. PMID: 17903235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters